Home > Browse Research > Life Sciences > Pharmaceuticals > Pricing

Pricing: market research reports

Pricing is a challenging area for life science products, be they drug therapies, devices or a new test product. In all industries products are priced to account for market conditions and cost. In healthcare pricing has to be considered in many cases along with reimbursement rates of standard treatments, the economic conditions and healthcare funding in many countries.

Pricing for pharmaceutical products requires a long-term approach.

A pricing strategy may be valid given cost and market conditions, but when considers that the earning period of a given therapy may be a decade, this must be accounted for in pricing. Market conditions will also be a factor, in pharmaceuticals, a company must consider the role generics play after patent expiration, generic threats may be present. Some companies have reacted to generic threats with underpricing strategy to reduce the impact of the threat.

Pricing market research reports and industry analysis

Pharmacy Retail Market in India 2013 5/8/2013 \| published by: Netscribes (India) Pvt. Ltd. ... projected towards significant growth due to the already existing varied disease profile as well as the emerging new diseases and the growing population size being affected by such diseases. The pharmacy sector forms the second ... \| read more...	$850.00
The Worldwide Guide to Pricing & Reimbursement 4/16/2013 \| published by: Espicom Healthcare Intelligence Provides insight into pharmaceutical pricing and reimbursement systems around the world! \| read more...	$995.00
Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players 4/8/2013 \| published by: GBI Research ... its latest research, Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players, which provides in-depth analysis of the key therapeutic ... \| read more...	$3,500.00
Healthcare, Regulatory and Reimbursement Landscape - Austria 3/31/2013 \| published by: GlobalData ... regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Finland 3/31/2013 \| published by: GlobalData ... healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Norway 3/31/2013 \| published by: GlobalData ... analysis regarding the healthcare, regulatory, and reimbursement landscape in Norway. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure. Most importantly, it ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Portugal 3/31/2013 \| published by: GlobalData ... and analysis of the healthcare, regulatory, and reimbursement landscape in Portugal. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, as well as the healthcare infrastructure. ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Colombia 2/15/2013 \| published by: GlobalData ... regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and provides insights on the demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Switzerland 2/15/2013 \| published by: GlobalData ... regarding the healthcare, regulatory, and reimbursement landscape in Switzerland. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the country’s healthcare infrastructure. Most importantly, it ... \| read more...	$1,995.00
Healthcare, Regulatory and Reimbursement Landscape - Egypt 2/15/2013 \| published by: GlobalData ... on Egypt’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights ... \| read more...	$1,995.00
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide 2/1/2013 \| published by: JustPharmaReports.com ... usually at launch - about the product’s value (clinical- and cost-effectiveness), budget impact and/or utilisation to optimise performance, whilst at the same time allowing patient access. For many products considered costly they are almost essential ... \| read more...	$1,050.00
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential 1/31/2013 \| published by: GBI Research ... 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential”. The report provides insights into the up-and-coming trends of a portion of the acquired orphan blood disorder pharmaceutical market by examining Idiopathic ... \| read more...	$3,500.00
Russia Pricing and Reimbursement 1/15/2013 \| published by: Datamonitor ... regional authorities creating their own lists, making market access especially complex. Features and benefits Provides an analysis of the recent regulatory changes and their possible impact to help you enter this market effectively and profitably ... \| read more...	$1,900.00
Pharmaceutical New Product Planning: Building the Framework for Brand Commercialization 1/1/2013 \| published by: Cutting Edge Information ... planning groups provide a critical commercial perspective — and their assessments, forecasting and insights influence critical go/no-go decisions at every step. When well-structured and adequately resourced, new product planning groups influence a range of commercialization ... \| read more...	$7,695.00
Italy: Market Access Tracker 11/29/2012 \| published by: Decision Resources ... years ($16.2 billion in 2011) and is steadily sliding down the global rankings. The relative decline of the Italian market reflects the government’s increasingly stringent cost-containment strategy. Faced with crippling debt, the Italian government has ... \| read more...	$4,000.00
Turkey: Market Access Tracker 11/29/2012 \| published by: Decision Resources ... a universal health insurance system have boosted demand for healthcare services, including prescription drugs. However, a tough pricing and reimbursement environment and restrictions on market access for new imported drugs present serious challenges for multinational ... \| read more...	$4,000.00
Europe: Market Access Tracker 11/14/2012 \| published by: Decision Resources ... the United Kingdom. Timely analysis of key events, regular webinar update presentations, and access to our team of experts will equip biopharmaceutical companies with the insight needed to evaluate the implications of the latest changes ... \| read more...	$4,000.00
US Pharmaceutical Industry – PEST Framework Analysis 11/1/2012 \| published by: Aruvian's R'search ... solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market. The US continues to generate the ... \| read more...	$200.00
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis 11/1/2012 \| published by: Aruvian's R'search ... The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market. Aruvian's R'search analyzes the Pharmaceutical Industry in ... \| read more...	$200.00
Conference Documentation: European Pharmaceutical Pricing & Reimbursement 10/29/2012 \| published by: SMI Publishing, Ltd ... and market access fields. Focusing on the development of novel pricing and market access strategies, this informative conference will bring together key opinion leaders in the field to provide attendees with an in depth look ... \| read more...	$788.78
China: Market Access Tracker 10/18/2012 \| published by: Decision Resources ... and South Korea. Timely analysis of key events, regular webinar update presentations, and access to our team of experts will equip biopharmaceutical companies with the insight needed to evaluate the implications of the latest changes ... \| read more...	$4,000.00
Asia Pacific: Market Access Tracker 10/17/2012 \| published by: Decision Resources ... and South Korea. Timely analysis of key events, regular webinar update presentations, and access to our team of experts will equip biopharmaceutical companies with the insight needed to evaluate the implications of the latest changes ... \| read more...	$4,000.00
United Kingdom: Market Access Tracker 10/1/2012 \| published by: Decision Resources ... launch delays, a relatively liberal regulatory environment, and a strong R&D base made the United Kingdom one of the most attractive markets in Europe for the research-based pharmaceutical industry. However, the commercial environment for manufacturers ... \| read more...	$4,000.00
Argentina: Market Access Tracker 9/27/2012 \| published by: Decision Resources ... outsiders. Foreign companies need to understand the structure of the Argentine healthcare system, the limitations of intellectual property protection, pricing trends, and coverage policies for prescription drugs. In addition, multinationals must be prepared for a ... \| read more...	$4,000.00
Brazil: Market Access Tracker 9/27/2012 \| published by: Decision Resources ... expectancy will boost demand for pharmaceuticals, but manufacturers will also have to contend with pressures such as limited reimbursement of drugs, strict price controls, and weak intellectual property protection. Please note, the PDF e-mail from ... \| read more...	$4,000.00

< prev 1 2 3 4 5 6 7 8 next >